SABR in early operable lung cancer: Time for evidence

The Lancet Oncology

Volumn 16, Issue 6, 2015, Pages 597-598

  Treasure, Tom ^a   Rintoul, Robert C ^b   Macbeth, Fergus ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c Wales Cancer Trials Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER REGISTRY; CANCER STAGING; CLINICAL EFFECTIVENESS; EARLY CANCER; EVIDENCE BASED MEDICINE; HUMAN; INTERMETHOD COMPARISON; LOBECTOMY; LYMPH NODE DISSECTION; NON SMALL CELL LUNG CANCER; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STEREOTACTIC BODY RADIATION THERAPY; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; MALE; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; TEMPORAL LOBECTOMY;

ANTERIOR TEMPORAL LOBECTOMY; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY;

EID: 84930252064     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(15)70225-1     Document Type: Note

References (10)

1. Chang JY, Senan S, Paul MA, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 2015, published online May 14. http://dx.doi.org/10.1016/S1470-2045(15)70168-3.
2. Doshi P, Dickersin K, Healy D, Vedula SS, Jefferson T Restoring invisible and abandoned trials: a call for people to publish the findings. BMJ 2013, 346:f2865.
3. Ramsay CR, Grant AM, Wallace SA, Garthwaite PH, Monk AF, Russell IT Statistical assessment of the learning curves of health technologies. Health Technol Assess 2001, 5:1-79.
4. Wu Y, Huang ZF, Wang SY, Yang XN, Ou W A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 2002, 36:1-6.
5. Blackstone EH, Lauer MS Caveat emptor: the treachery of work-up bias. J Thorac Cardiovasc Surg 2004, 128:341-344.
6. Berwick DM The science of improvement. JAMA 2008, 299:1182-1184.
7. Treasure T, Russell C, Morton D, Macbeth F, Utley M Surgical resection of lung cancer in England: more operations but no trials to test their effectiveness. Thorax 2012, 67:759-761.
8. Russell RCG, Treasure T Counting the cost of cancer surgery for advanced and metastatic disease. Br J Surg 2012, 99:449-450.
9. Paul S, Isaacs AJ, Treasure T, Altorki NK, Sedrakyan A Long term survival with thoracoscopic versus open lobectomy: propensity matched comparative analysis using SEER-Medicare database. BMJ 2014, 349:g5575.
10. Cancer patient experience survey 2011/12. National report Department of Health, (accessed May 1, 2015). https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/212860/Cancer-Patient-Experience-Survey-National-Report-2011-12.pdf.